Scheme

LIC MF Healthcare Fund

Holds 25 companies worth ₹96.9 Cr in Sept 2026.

Fund house
LICThe fund house that runs this scheme.
AUM
₹99.4 CrLIC MF Healthcare Fund's AUM at the end of 30 Sept 2026, as AMFI reports it. Down 3.6% on Aug 2026, ₹103 Cr.
Largest holding
Sun Pharmaceutical Ind LtdSun Pharmaceutical Ind Ltd is 9.6% of this scheme's NAV.
Fund manager
Sudhanshu AsthanaRuns it since 1 Apr 2026, as the fund house dates it. With Dhaval Sangoi (co-manager).

Holdings^{(Mar 2019 – Sept 2026)}

Holdings in Sept 2026. Tick up to 2 to plot them.
Plot	25 companies ·	₹ Cr
	Sun Pharmaceutical Ind Ltd	9.5
	Divi s Laboratories Limited	9
	Neuland Laboratories Limited	6.1
	Torrent Pharmaceuticals Limited	6
	Apollo Hospitals Enterprise Limited	5.7
	Aurobindo Pharma	5.2
	Navin Flourine International Ltd	5
	Cadila Healthcare	4.9
	Aster DM Healthcare Limited	4.6
	Fortis Healthcare Limited	3.7
	Metropolis Healthcare Limited	3.3
	Gland Pharma Limited	3.2
	Mankind Pharma Limited	3.1
	Nephrocare Health Services Ltd	3
	Max Healthcare Institute Limited	3
	Cohance Lifesciences Limited	2.9
	Glenmark Pharmaceuticals	2.6
	Global Health Limited	2.6
	Dr Agarwal s Health Care Limited	2.4
	Biocon	2.4
	IPCA Laboratories Limited	2.3
	Onesource Speciality Pharma Ltd	2.3
	Piramal Pharma Limited	1.4
	Syngene International Limited	1.4
	Artemis Medicare Services Limited	1.3

Sun Pharmaceutical Ind Ltd
Divi s Laboratories Limited

Market value of each ticked company in LIC MF Healthcare Fund, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.
Month	Sun Pharmaceutical Ind Ltd	Divi s Laboratories Limited
Sept 2025	₹8.6 Cr	₹3.5 Cr
Oct 2025	₹9.1 Cr	₹4.2 Cr
Nov 2025	₹9.9 Cr	₹4 Cr
Dec 2025	₹9 Cr	₹3.9 Cr
Jan 2026	₹8.4 Cr	₹3.7 Cr
Feb 2026	₹9.1 Cr	₹4 Cr
Mar 2026	₹9.2 Cr	₹3.7 Cr
Apr 2026	₹9.5 Cr	₹4 Cr
May 2026	₹9.4 Cr	₹6.7 Cr
Jun 2026	₹9.8 Cr	₹6.6 Cr
Jul 2026	₹10.4 Cr	₹9.3 Cr
Aug 2026	₹10.4 Cr	₹9.6 Cr
Sept 2026	₹9.5 Cr	₹9 Cr

Fig. 1.Market value of each ticked company in LIC MF Healthcare Fund, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Allocation^{(Sept 2026)}

Market cap

		% of NAV
Large Cap	4	30.45

Mid Cap	9	31.99

Small Cap	12	35.09

Cash & others		2.47

Sectors

Companies

Fig. 2.This scheme's holdings, by market cap, by sector and by company. Hover a slice or a row; click a slice to open it.

Buying and selling, month by month^{(Oct 2025 – Sept 2026)}

Buying and selling, month by month. Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Fig. 3.Change in market value since the previous month, ₹ crore. Month end. Source: AMC monthly portfolio disclosures.

Portfolio^{(Sept 2026)}

Every holding in Sept 2026: its shares, market value (₹ crore) and % of NAV. Month end. Source: AMC monthly portfolio disclosures. Click a column's header to sort by it.

Sun Pharmaceutical Ind Ltd	Equity	Pharmaceuticals & Biotechnology	52.4K	9.5	9.59
Divi s Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	9.7K	9	9.07
Neuland Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	2.86K	6.1	6.14
Torrent Pharmaceuticals Limited	Equity	Pharmaceuticals & Biotechnology	12.5K	6	6.04
Apollo Hospitals Enterprise Limited	Equity	Healthcare Services	7K	5.7	5.75
Aurobindo Pharma	Equity	Pharmaceuticals & Biotechnology	31.1K	5.2	5.23
Navin Flourine International Ltd	Equity	Chemicals & Petrochemicals	6K	5	4.98
Cadila Healthcare	Equity	Pharmaceuticals & Biotechnology	42.5K	4.9	4.97
Aster DM Healthcare Limited	Equity	Healthcare Services	65.8K	4.6	4.61
Fortis Healthcare Limited	Equity	Healthcare Services	48.6K	3.7	3.77
Metropolis Healthcare Limited	Equity	Healthcare Services	61.5K	3.3	3.35
Gland Pharma Limited	Equity	Pharmaceuticals & Biotechnology	11K	3.2	3.20
Mankind Pharma Limited	Equity	Pharmaceuticals & Biotechnology	12.3K	3.1	3.11
Nephrocare Health Services Ltd	Equity	Healthcare Services	46K	3	3.05
Max Healthcare Institute Limited	Equity	Healthcare Services	32K	3	2.99
Cohance Lifesciences Limited	Equity	Pharmaceuticals & Biotechnology	66K	2.9	2.95
Glenmark Pharmaceuticals	Equity	Pharmaceuticals & Biotechnology	11.1K	2.6	2.61
Global Health Limited	Equity	Healthcare Services	18.9K	2.6	2.59
Dr Agarwal s Health Care Limited	Equity	Healthcare Services	51K	2.4	2.46
Biocon	Equity	Pharmaceuticals & Biotechnology	63.5K	2.4	2.37
IPCA Laboratories Limited	Equity	Pharmaceuticals & Biotechnology	12K	2.3	2.33
Onesource Speciality Pharma Ltd	Equity	Pharmaceuticals & Biotechnology	15K	2.3	2.30
Piramal Pharma Limited	Equity	Pharmaceuticals & Biotechnology	69K	1.4	1.43
Syngene International Limited	Equity	Healthcare Services	37.4K	1.4	1.38
Artemis Medicare Services Limited	Equity	Healthcare Services	36.2K	1.3	1.26

Fig. 4.Every holding in Sept 2026: its shares, market value (₹ crore) and % of NAV. Month end. Source: AMC monthly portfolio disclosures.